WO1992006183A1 - Procedes de traitement a la cellulase de tissus contenant du coton - Google Patents

Procedes de traitement a la cellulase de tissus contenant du coton Download PDF

Info

Publication number
WO1992006183A1
WO1992006183A1 PCT/US1991/007275 US9107275W WO9206183A1 WO 1992006183 A1 WO1992006183 A1 WO 1992006183A1 US 9107275 W US9107275 W US 9107275W WO 9206183 A1 WO9206183 A1 WO 9206183A1
Authority
WO
WIPO (PCT)
Prior art keywords
cellulase
cbh
components
type components
cotton
Prior art date
Application number
PCT/US1991/007275
Other languages
English (en)
Inventor
Kathleen A. Clarkson
Geoffrey L. Weiss
Edmund A. Larenas
Original Assignee
Genencor International, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genencor International, Inc. filed Critical Genencor International, Inc.
Priority to JP3517030A priority Critical patent/JPH06502223A/ja
Priority to EP91918328A priority patent/EP0551386B1/fr
Priority to DE69133352T priority patent/DE69133352T2/de
Priority to AT91918328T priority patent/ATE257511T1/de
Publication of WO1992006183A1 publication Critical patent/WO1992006183A1/fr
Priority to FI931492A priority patent/FI931492A0/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01004—Cellulase (3.2.1.4), i.e. endo-1,4-beta-glucanase
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/16—Organic compounds
    • C11D3/38—Products with no well-defined composition, e.g. natural products
    • C11D3/386—Preparations containing enzymes, e.g. protease or amylase
    • C11D3/38645—Preparations containing enzymes, e.g. protease or amylase containing cellulase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2405—Glucanases
    • C12N9/2434—Glucanases acting on beta-1,4-glucosidic bonds
    • C12N9/2437—Cellulases (3.2.1.4; 3.2.1.74; 3.2.1.91; 3.2.1.150)
    • D—TEXTILES; PAPER
    • D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
    • D06M—TREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
    • D06M16/00—Biochemical treatment of fibres, threads, yarns, fabrics, or fibrous goods made from such materials, e.g. enzymatic
    • D06M16/003—Biochemical treatment of fibres, threads, yarns, fabrics, or fibrous goods made from such materials, e.g. enzymatic with enzymes or microorganisms
    • D—TEXTILES; PAPER
    • D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
    • D06M—TREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
    • D06M2200/00—Functionality of the treatment composition and/or properties imparted to the textile material
    • D06M2200/50—Modified hand or grip properties; Softening compositions

Definitions

  • the present invention is directed to improved methods for treating cotton-containing fabrics with cellulase as well as to the fabrics produced from these methods.
  • the improved methods of the present invention are directed to contacting cotton-containing fabrics with an aqueous solution containing a fungal cellulase composition which comprises one or more EG type components and which contains low concentrations of CBH I type components.
  • a fungal cellulase composition which comprises one or more EG type components and which contains low concentrations of CBH I type components.
  • the resulting fabric possesses the expected enhancements in, for example, feel, appearance, and/or softening, etc., as compared to the fabric prior to treatment and the fabric also possesses decreased strength loss as compared to the fabric treated with a cellulase composition containing higher concentrations of CBH I type components.
  • cotton-containing fabrics can be treated with cellulase in order to impart desirable properties to the fabric.
  • cellulase has been used to improve the feel and/or appearance of cotton-containing fabrics, to remove surface fibers from cotton-containing knits, for imparting a stone washed appearance to cotton- containing denims and the like.
  • Japanese Patent Application Nos. 58-36217 and 58-54032 as well as Ohishi et al., "Reformation of Cotton Fabric by Cellulase” and JTN December 1988 journal article "What's New — Weight Loss Treatment to Soften the Touch of Cotton Fabric” each disclose that treatment of cotton-containing fabrics with cellulase results in an improved feel for the fabric. It is generally believed that this cellulase treatment removes cotton fuzzing and/or surface fibers which reduces the weight of the fabric. The combination of these effects imparts improved feel to the fabric, i.e., the fabric feels more like silk.
  • a common problem associated with the treatment of such cotton-containing fabrics with a cellulase solution is that the treated fabrics exhibit significant strength loss as compared to the untreated fabric. Strength loss arises because the cellulase hydrolyzes cellulose ( ⁇ -l,4-glucan linkages) which, in turn, can result in a breakdown of a portion of the cotton polymer. As more and more cotton polymers are disrupted (brokendown) , the tensile strength of the fabric is reduced.
  • the fungal cellulase composition employed herein comprises one or more EG type components and one or more CBH type components wherein said cellulase composition has a protein weight ratio of all EG type components to all CBH type components of greater than 5:1.
  • the fungal cellulase composition comprises at least about 10 weight percent and preferably at least about 20 weight percent of EG components based on the total weight of protein in the cellulase composition.
  • FIG. 1 is an outline of the construction of p ⁇ CBHlpyr .
  • FIG. 2 illustrates deletion of the T ⁇ reesei gene by integration of the larger EcoRI fragment from p ⁇ CBHIpyr4 at the cbhl locus on one of the T. reesei chromosomes.
  • FIG. 4 is an autoradiograph of DNA from a ______ reesei strain GC69 transformed with EcoRI digested P ⁇ CBHIPV ⁇ 4 using a 32 P labelled plntCBHI as the probe.
  • the sizes of molecular weight markers are shown in kilobase pairs to the left of the Figure.
  • FIG. 5 is an isoelectric focusing gel displaying the proteins secreted by the wild type and by transformed strains of TL _ reesei.
  • Lane A of the isoelectric focusing gel employs partially purified CBHI from T. reesei; Lane B employs a wild type T___, reesei : Lane C employs protein from a TV s . reesei strain with the cbhl gene deleted; and Lane D employs protein from a T. reesei strain with the cbhl and cbh2 genes deleted.
  • the right hand side of the figure is marked to indicate the location of the single proteins found in one or more of the secreted proteins.
  • FIG. 6A is a representation of the T. reesei cbh2 locus, cloned as a 4.1 kb EcoRI fragment on genomic DNA and FIG. 6B is a representation of the cbh2 gene deletion vector pP ⁇ CBHII.
  • FIG. 8 is a diagram of the plasmid pEGIpyr4.
  • FIG. 9 illustrates the RBB-CMC activity profile of an acidic EG enriched fungal cellulase composition (CBH I and II deleted) derived from
  • FIG. 14 is a diagram of the site specific alterations made in the e ⁇ ll and cbhl genes to create convenient restriction endonuclease cleavage sites.
  • the upper line shows the original DNA sequence
  • the changes introduced are shown in the middle line
  • the new sequence is shown in the lower line.
  • FIG. 17 is a diagram of the plasmid pEGII::P-l.
  • the companion material employed in the fabric can include one or more non-cotton fibers including synthetic fibers such as polyamide fibers (for example, nylon 6 and nylon 66) , acrylic fibers (for example, polyacrylonitrile fibers) , and polyester fibers (for example, polyethylene terephthalate) , polyvinyl alcohol fibers (for example, Vinylon) , polyvinyl chloride fibers, polyvinylidene chloride fibers, polyurethane fibers, polyurea fibers and aramid fibers. It is contemplated that regenerated cellulose, such as rayon, could be used as a substitute for cotton in the methods of this invention.
  • synthetic fibers such as polyamide fibers (for example, nylon 6 and nylon 66) , acrylic fibers (for example, polyacrylonitrile fibers) , and polyester fibers (for example, polyethylene terephthalate) , polyvinyl alcohol fibers (for example, Vinylon) , polyvinyl chloride fibers, polyvinylidene chlor
  • finishing means the application of a sufficient amount of finish to a cotton-containing fabric so as to substantially prevent cellulolytic activity of the cellulase on the fabric. Finishes are generally applied at or near the end of the manufacturing process of the fabric for the purpose of enhancing the properties of the fabric, for example, softness, drapability, etc. , which additionally protects the fabric from reaction with cellulases. Finishes useful for finishing a cotton-containing fabric are well known in the art and include resinous materials, such as melamine, glyoxal, or ureaformaldehyde, as well as waxes, silicons, fluoroche icals and quaternaries. When so finished, the cotton-containing fabric is substantially less reactive to cellulase.
  • fungal cellulases generally have their optimum activity in the acidic or neutral pH range although some fungal cellulases are known to possess significant activity under neutral and slightly alkaline conditions, i.e., for example, cellulase derived from Humicola insolens is known to have activity in neutral to slightly alkaline conditions.
  • Fungal cellulases are known to be comprised of several enzyme classifications having different substrate specificity, enzymatic action patterns, and the like. Additionally, enzyme components within each classification can exhibit different molecular weights, different degrees of glycosylation, different isoelectric points, different substrate specificity etc.
  • fungal cellulases can contain cellulase classifications which include endoglucanases (EGs) , exo-cellobiohydrolases (CBHs) , 3-glucosidases (BGs) , etc.
  • a fungal cellulase composition produced by a naturally occurring fungal source and which comprises one or more CBH and EG components wherein each of these components is found at the ratio produced by the fungal source is sometimes referred to herein as a "complete fungal cellulase system" or a “complete fungal cellulase composition” to distinguish it from the classifications and components of cellulase isolated therefrom, from incomplete cellulase compositions produced by bacteria and some fungi, or from a cellulase composition obtained from a microorganism genetically modified so as to overproduce, underproduce, or not produce one or more of the CBH and/or EG components of cellulase.
  • cellulase systems can be produced either by solid or submerged culture, including batch, fed-batch and continuous-flow processes.
  • the collection and purification of the cellulase systems from the fermentation broth can also be effected by procedures known per se in the art.
  • Endoglucanase (“EG”) type components refer to all of those fungal cellulase components or combination of components which exhibit textile activity properties similar to the endoglucanase components of Trichoderma reesei.
  • the endoglucanase components cf Trichoderma reesei (specifically, EG I, EG II, EG III, and the like either alone or in combination) impart improved feel, improved appearance, softening, color enhancement, and/or a stone washed appearance to cotton-containing fabrics (as compared to the fabric prior to treatment) when these components are incorporated into a textile treatment medium and the fabric is treated with this medium.
  • treatment of cotton-containing fabrics with endoglucanase components of Trichoderma reesei results in less strength loss as compared to the strength loss arising from treatment with a similar composition but which additionally contains CBH I type components.
  • endoglucanase type components are those fungal cellulase components which impart improved feel, improved appearance, softening, color enhancement, and/or a stone washed appearance to cotton-containing fabrics (as compared to the fabric before treatment) when these components are incorporated into a medium used to treat the fabrics and which impart reduced strength loss to cotton- containing fabrics as compared to the strength loss arising from treatment with a similar cellulase composition but which additionally contains CBH I type components.
  • Such endoglucanase type components may not include components traditionally classified as endoglucanases using activity tests such as the ability of the component (a) to hydrolyze soluble cellulose derivatives such as carboxymethylcellulose (CMC) , thereby reducing the viscosity of CMC containing solutions, (b) to readily hydrolyze hydrated forms of cellulose such as phosphoric acid swollen cellulose (e.g., Walseth cellulose) and hydrolyze less readily the more highly crystalline forms of cellulose (e.g., Avicel, SOlkafloc, etc.).
  • activity tests such as the ability of the component (a) to hydrolyze soluble cellulose derivatives such as carboxymethylcellulose (CMC) , thereby reducing the viscosity of CMC containing solutions, (b) to readily hydrolyze hydrated forms of cellulose such as phosphoric acid swollen cellulose (e.g., Walseth cellulose) and hydrolyze less readily the more highly crystalline forms of cellulose (e
  • Fungal cellulases can contain more than one EG type component.
  • the different components generally have different isoelectric points, different molecular weights, different degrees of glycosylation, different substrate specificity, different enzymatic action patterns, etc.
  • the different isoelectric points of the components allow for their separation via ion exchange chromatography and the like.
  • the isolation of components from different fungal sources is known in the art. See, for example, Bjork et al., U.S. Serial No. 07/422,814, Jrin et al.. International Application WO 89/09259, Wood et al.. Biochemistry and Genetics of Cellulose Degradation, pp. 31 to 52 (1988); Wood et al.. Carbohydrate Research, Vol.
  • EG type components may give a synergistic response in imparting enhancements to the cotton-containing fabrics as well as imparting reduced strength loss as compared to a single EG component.
  • a single EG type component may be more stable or have a broader spectrum of activity over a range of pHs.
  • the EG type components employed in this invention can be either a single EG type component or a combination of two or more EG type components. When a combination of components is employed, the EG type component may be derived from the same or different fungal sources.
  • a preferred method for the preparation of cellulase compositions described herein is by genetically modifying a microorganism so as to overproduce one or more acidic EG type components.
  • the deletion of the genes responsible for producing CBH I type and/or CBH II type cellulase components would have the effect of enriching the amount of EG components present in the cellulase composition.
  • fungal cellulase compositions can be used herein from fungal sources which produce low concentrations of CBH I type components.
  • a requisite amount of one or more CBH I type components purified by conventional procedures can be added to a cellulase composition produced from a microorganism genetically engineered so as to be incapable of producing CBH I type components so as to achieve a specified ratio of EG type components to CBH I type components, i.e., a cellulase composition free of all CBH type components so as to be enriched in EG type components can be formulated to contain 2 weight percent of a CBH I type component (or CBH II type component) merely by adding this amount of a purified CBH I type component (or CBH II type component) to the cellulase composition.
  • one or more additives can be added to the cellulase composition to effectively "turn-off", directly or indirectly, some or all of the CBH I type activity as well as other CBH activity.
  • the resulting composition is considered to be a composition suitable for use in this invention if the amount of additive employed is sufficient to lower the CBH I type activity to levels equal to or less than the CBH I type activity levels achieved by using the cellulase compositions described herein.
  • the BG component When employed in textile treatment solutions, the BG component is generally added in an amount sufficient to prevent inhibition by cellobiose of any CBH and EG components found in the cellulase composition.
  • the amount of BG component added depends upon the amount of cellobiose produced in the textile composition which can be readily determined by the skilled artisan.
  • the weight percent of BG component relative to any CBH type components present in the cellulase composition is preferably from about 0.2 to about 10 weight percent and more preferably, from about 0.5 to about 5 weight percent.
  • Preferred fungal cellulases for use in preparing the fungal cellulase compositions used in this invention are those obtained from Trichoderma reesei. Trichoderma koningii. Pencillu sp.
  • CELLUCAST available from Novo Industry, Copenhagen, Denmark
  • RAPIDASE available from Gist Brocades, N.V., Delft, Holland
  • CYTOLASE 123 available from Genencor International, South San Francisco
  • fungal cellulases can be readily isolated by art recognized fermentation and isolation procedures.
  • the buffer(s) selected for use with the cellulase composition employed can be readily determined by the skilled artisan taking into account the pH range and optimum for the cellulase composition employed as well as the pH of the cellulase solution.
  • the buffer employed is one which is compatible with the cellulase composition and which will maintain the pH of the cellulase solution within the pH range required for optimal activity.
  • Suitable buffers include sodium citrate, ammonium acetate, sodium acetate, disodium phosphate, and any other art recognized buffers.
  • methods for improving both the feel and appearance of cotton-containing fabrics include contacting the fabric with an aqueous solution containing cellulase under conditions so that the solution is agitated and so that a cascading effect of the cellulase solution over the cotton-containing fabric is achieved.
  • Such methods result in improved feel and appearance of the so treated cotton- containing fabric and are described in U.S. Serial No. 07/598,506, filed October 16, 1990 and which is incorporated herein by reference in its entirety.
  • the present invention is an improvement over prior art methods for treating cotton-containing fabrics insofar as the present invention employs a specific cellulase composition which minimizes strength loss in the treated fabric.
  • the cellulase composition employed herein is a fungal cellulase composition which comprises one or more EG type components and one or more CBH type components wherein the cellulase composition has a weight ratio of all EG type components to all CBH type components of greater than 5:1
  • the use of the cellulase compositions described herein also result in fabric/color enhancement of stressed cotton- containing fabrics.
  • the fabric can become stressed and when so stressed, it will contain broken and disordered fibers. Such fibers detrimentally impart a worn and dull appearance to the fabric.
  • the so stressed fabric is subject to fabric/color enhancement. This is believed to arise by removal of some of the broken and disordered fibers which has the effect of restoring the appearance of the fabric prior to becoming stressed.
  • these cellulase compositions will cause less redeposition of dye. It is also contemplated that these anti-redeposition properties can be enhanced for one or more specific EG type component(s) as compared to other components.
  • the fungal cellulase compositions described above are employed in an aqueous solution which contains cellulase and other optional ingredients including, for example, a buffer, a surfactant, a scouring agent, and the like.
  • concentration of the cellulase composition employed in this solution is generally a concentration sufficient for its intended purpose. That is to say that an amount of the cellulase composition is employed to provide the desired enhancement(s) to the cotton-containing fabric.
  • the amount of the cellulase composition employed is also dependent on the equipment employed, the process parameters employed (the temperature of the cellulase solution, the exposure time to the cellulase solution, and the like) , the cellulase activity (e.g., a cellulase solution will require a lower concentration of a more active cellulase composition as compared to a less active cellulase composition) , and the like.
  • concentration of the cellulase composition can be readily determined by the skilled artisan based on the above factors as well as the desired effect.
  • the concentration of the cellulase composition in the cellulase solution employed herein is from about 0.01 gram/liter of cellulase solution to about 10.0 grams/liter of cellulase solution; and more preferably, from about 0.05 grams/liter of cellulase solution to about 2 gram/liter of cellulase solution.
  • the cellulase concentration recited above refers to the weight of total protein
  • the concentration of buffer in the aqueous cellulase solution is that which is sufficient to maintain the pH of the solution within the range wherein the employed cellulase exhibits activity which, in turn, depends on the nature of the cellulase employed.
  • concentration of buffer employed will depend on several factors which the skilled artisan can readily take into account.
  • the buffer as well as the buffer concentration' are selected so as to maintain the pH of the cellulase solution within the pH range required for optimal cellulase activity. In general, buffer concentration in the cellulase solution is about 0.005 N and greater.
  • the concentration of the buffer in the cellulase solution is from about 0.01 to about 0.5 N, and more preferably, from about 0.05 to about 0.15 N. It is possible that increased buffer concentrations in the cellulase solution may enhance the rate of tensile strength loss of the treated fabric.
  • the cellulase solution can optionally contain a small amount of a surfactant, i.e., less than about 2 weight percent, and preferably from about 0.01 to about 2 weight percent.
  • a surfactant include any surfactant compatible with the cellulase and the fabric including, for example, anionic, non-ionic and ampholytic surfactants.
  • Suitable anionic surfactants for use herein include linear or branched alkylbenzenesulfonates; alkyl or alkenyl ether sulfates having linear or branched alkyl groups or alkenyl groups; alkyl or alkenyl sulfates; olefinsulfonates; alkanesulfonates and the like.
  • Suitable counter ions for anionic surfactants include alkali metal ions such as sodium and potassium; alkaline earth metal ions such as calcium and magnesium; ammonium ion; and alkanolamines having 1 to 3 alkanol groups of carbon number 2 or 3.
  • Ampholytic surfactants include quaternary ammonium salt sulfonates, betaine-type ampholytic surfactants, and the like. Such ampholytic surfactants have both the positive and negative charged groups in the same molecule.
  • Nonionic surfactants generally comprise polyoxyalkylene ethers, as well as higher fatty acid alkanolamides or alkylene oxide adduct thereof, fatty acid glycerine monoesters, and the like.
  • the liquor ratios i.e., the ratio of weight of cellulase solution to the weight of fabric, employed herein is generally an amount sufficient to achieve the desired enhancement in the cotton-containing fabric and is dependent upon the process used and the enhancement to be achieve.
  • the liquor ratios are generally from about 0.1:1 and greater, and more preferably greater than about 1:1 and even more preferably greater than about 10:1.
  • Use of liquor ratios of greater than about 50:1 are usually not preferred from an economic viewpoint.
  • reaction temperatures for cellulase treatment are governed by two competing factors. Firstly, higher temperatures generally correspond to enhanced reaction kinetics, i.e., faster reactions, which permit reduced reaction times as compared to reaction times required at lower temperatures. Accordingly, reaction temperatures are generally at least about 30 ⁇ C and greater.
  • cellulase is a protein which loses activity beyond a given reaction temperature which temperature is dependent on the nature of the cellulase used.' Thus, if the reaction temperature is permitted to go too high, then the cellulolytic activity is lost as a result of the denaturing of the cellulase. As a result, the maximum reaction temperatures employed herein are generally about 65°C. In view of the above, reaction temperatures are generally from about 30°C to about 65°C; preferably, from about 35°C to about 60°C; and more preferably, from about 35°C to about 50°C.
  • Reaction times are generally from about 0.1 hours to about 24 hours and, preferably, from about 0.25 hours to about 5 hours.
  • the cotton-containing fabrics treated in the methods described above using such cellulase compositions possess reduced strength loss as compared to the same cotton-containing fabric treated in the same manner with a complete fungal cellulase composition.
  • a concentrate can be prepared for use in the methods described herein.
  • Such concentrates would contain concentrated amounts of the cellulase composition described above, buffer and surfactant, preferably in an aqueous solution.
  • the concentrate can readily be diluted with water so as to quickly and accurately prepare cellulase solutions having the requisite concentration of these additives.
  • such concentrates will comprise from about 0.1 to about 20 weight percent of a cellulase composition described above (protein) ; from about 10 to about 50 weight percent buffer; from about 10- to about 50 weight percent surfactant; and from about 0 to 80 weight percent water.
  • aqueous concentrates When aqueous concentrates are formulated, these concentrates can be diluted by factors of from about 2 to about 200 so as to arrive at the requisite concentration of the components in the cellulase solution. As is readily apparent, such concentrates will permit facile formulation of the cellulase solutions as well as permit feasible transportation of the concentration to the location where it will be used.
  • the cellulase composition as described above can be added to the concentrate either in a liquid diluent, in granules, in emulsions, in gels, in pastes, and the like. Such forms are well known to the skilled artisan.
  • the cellulase composition is generally a granule, a powder, an agglomerate and the like.
  • the granules are preferably formulated so as to contain a cellulase protecting agent. See, for instance, U.S. Serial No. 07/642,669, filed January 17, 1991 as Attorney Docket No. 010055-073 and entitled "GRANULES CONTAINING BOTH AN ENZYME AND AN ENZYME PROTECTING AGENT AND DETERGENT
  • the granule can be formulated so as to contain materials to reduce the rate of dissolution of the granule into the wash medium.
  • materials and granules are disclosed in U.S. Serial No. 07/642,596 filed on January 17, 1991 as Attorney Docket No. GCS-171-US1 and entitled "GRANULAR COMPOSITIONS” which application is incorporated herein by reference in its entirety.
  • cellulase compositions described herein can additionally be used in a pre-wash and as a pre-soak either as a liquid or a spray. It is still further contemplated that the cellulase compositions described herein can also be used in home use as a stand alone composition suitable for enhancing color and appearance of fabrics. See, for example, U.S.
  • Patent No. 4,738,682 which is incorporated herein by reference in its entirety.
  • Examples 1-12 and 22-30 demonstrate the preparation of Trichoderma reesei genetically engineered so as to be incapable of producing one or more cellulase components or so as to overproduce specific cellulase components.
  • the pyr4 gene encodes orotidine-5'- monophosphate decarboxylase , an enzyme required for the biosynthesis of uridine.
  • the toxic inhibitor 5- fluoroorotic acid (FOA) is incorporated into uridine by wild-type cells and thus poisons the cells.
  • FAA 5- fluoroorotic acid
  • cells defective in the pyr4 gene are resistant to this inhibitor but require uridine for growth. It is, therefore, possible to select for pyr4 derivative strains using FOA.
  • spores of T. reesei strain RL-P37 (Sheir-Neiss, G. and Montenecourt, B.S. , Appl. Microbiol. Biotechnol. 20, p.
  • a cbhl gene encoding the CBHI protein was cloned from the genomic DNA of T. reesei strain RL- P37 by hybridization with an oligonucleotide probe designed on the basis of the published sequence for this gene using known probe synthesis methods
  • the cbhl gene resides on a 6.5 kb Pstl fragment and was inserted into Pstl cut pUC4K (purchased from Pharmacia Inc. , Piscataway, NJ) replacing the Kan r gene of this vector using techniques known in the art, which techniques are set forth in Maniatis et al., (1989) and incorporated herein by reference.
  • the resulting plasmid, pUC4K::cbhl was then cut with Hindlll and the larger fragment of about 6 kb was isolated and religated to give pUC4K: :cbhl ⁇ H/H (see FIG. 1). This procedure removes the entire cbhl coding sequence and approximately 1.2 kb upstream and 1.5 kb downstream of flanking sequences. Approximately, 1 kb of flanking DNA from either end of the original Pstl fragment remains.
  • the T. reesei pyr4 gene was cloned as a 6.5 kb
  • FIG. 1 illustrates the construction of this plasmid.
  • Mycelium was obtained by inoculating 100 ml of YEG (0.5% yeast extract, 2% glucose) in a 500 ml flask with about 5 x 10 7 T. reesei GC69 spores (the pyr4 ⁇ derivative strain) . The flask was then incubated at 37°C with shaking for about 16 hours. The mycelium was harvested by centrifugation at 2,750 x g.
  • the harvested mycelium was further washed in a 1.2 M sorbitol solution and resuspended in 40 ml of a solution containing 5 mg/ml Novozym R 234 solution (which is the tradename for a multicomponent enzyme system containing 1,3-alpha- glucanase, 1,3-beta-glucanase, laminarinase, xylanase, chitinase and protease from Novo Biolabs, Danbury, CT) ; 5 mg/ml MgS0 4 .7H 2 0; 0.5 mg/ml bovine serum albumin; 1.2 M sorbitol.
  • Novozym R 234 solution which is the tradename for a multicomponent enzyme system containing 1,3-alpha- glucanase, 1,3-beta-glucanase, laminarinase, xylanase, chitinase and proteas
  • the protoplasts were removed from the cellular debris by filtration through Miracloth (Calbiochem Corp, La Jolla, CA) and collected by centrifugation at 2,000 x g.
  • the protoplasts were washed three times in 1.2 M sorbitol and once in 1.2 M sorbitol, 50 mM CaCl 2 , centrifuged and resuspended at a density of approximately 2 x 10* protoplasts per ml of 1.2 M sorbitol, 50 mM CaCl 2 .
  • the protoplast/medium mixture was then poured onto a solid medium containing the same Vogel's medium as stated above. No uridine was present in the medium and therefore only transformed colonies were able to grow as a result of complementation of the pyr4 mutation of strain GC69 by the wild type pyr4 gene insert in p ⁇ CBHIp ⁇ r4. These colonies were subsequently transferred and purified on a solid Vogel's medium N containing as an additive, 1% glucose and stable transformants were chosen for further analysis.
  • DNA was isolated from the transformants obtained in Example 4 after they were grown in liquid Vogel's medium N containing 1% glucose.
  • transformant DNA samples were further cut with a Pstl restriction enzyme and subjected to agarose gel electrophoresis. The gel was then blotted onto a Nytran membrane filter and hybridized with a 32 P labelled p ⁇ CBHIpyr4 probe. The probe was selected to identify the native cbhl gene as a 6.5 kb Pstl fragment, the native pyr4 gene and any DNA sequences derived from the transforming DNA fragment.
  • the radioactive bands from the hybridization were visualized by autoradiography.
  • the autoradiograph is seen in FIG. 3.
  • Five samples were run as described above, hence samples A, B, C, D, and E.
  • Lane E is the untransformed strain GC69 and was used as a control in the present analysis.
  • Lanes A-D represent transformants obtained by the methods described above.
  • the numbers on the side of the autoradiograph represent the sizes of molecular weight markers.
  • lane D does not contain the 6.5 kb CBHI band, indicating that this gene has been totally deleted in the transformant by integration of the DNA fragment at the cbhl gene.
  • the cbhl deleted strain is called P37P ⁇ CBHI.
  • Figure 2 outlines the deletion of the T.
  • sample A contained the cbhl gene, as indicated by the band at 6.5 kb; however the transformant, sample B, does not contain this 6.5 kb band and therefore does not contain the cbhl gene and does not contain any sequences derived from the pUC plasmid.
  • Tween 80 0.000016% CuS0 4 .5H 2 0, 0.001% FeS0 4 .7H 2 0, 0.000128% ZnS0 4 .7H 2 0, 0.0000054% Na 2 M ⁇ 0 4 .2H 2 0 , 0.0000007% MnC1.4H20.
  • the medium was incubated with shaking in a 250 ml flask at 37 °C for about 48 hours .
  • the resulting mycelium was collected by filtering through Miracloth (Calbiochem Corp.) and washed two or three times with 17 mM potassium phosphate.
  • the mycelium was finally suspended in 17 mM potassium phosphate with l mM sophorose and further incubated for 24 hours at 30 ⁇ C with shaking.
  • Lane C is the supernatant from strain P37P ⁇ CBHI produced according to the methods of the present invention.
  • the position of various cellulase components are labelled CBHI, CBHII, EGI, EGII, and EGIII. Since CBHI constitutes 50% of the total extracellular protein, it is the major secreted protein and hence is the darkest band on the gel. This isoelectric focusing gel clearly shows depletion of the CBHI protein in the P37P ⁇ CBHI strain.
  • the cbh2 gene of T. reesei. encoding the CBHII protein has been cloned as a 4.1 kb EcoRI fragment of genomic DNA which is shown diagramatically in FIG. 6A (Chen et al., 1987, Biotechnology. 5:274- 278). This 4.1 kb fragment was inserted between the EcoRI sites of pUC4XL.
  • the latter plasmid is a pUC derivative (constructed by R.M. Berka, Genencor International Inc.) which contains a multiple cloning site with a symetrical pattern of restriction endonuclease sites arranged in the order shown here: EcoRI. BamHI. Sad.
  • T. reesei p ⁇ r4 gene was excised from pTpyr2 (see Example 2) on a 1.6 kb Nhel-Sphl fragment and inserted between the Sphl and Xbal sites of pUC219 (see Example 25) to create p219M (Smith et al., 1991, Curr. Genet 19 p. 27-33) .
  • the pyr4 gene was then removed as a Hindlll-Clal fragment having seven bp of DNA at one end and six bp of DNA at the other end derived from the pUC219 multiple cloning site and inserted into the Hindlll and Clal sites of the cbh2 gene to form the plasmid pP ⁇ CBHII (see FIG. 6B) .
  • Protoplasts of strain P37P ⁇ CBHIPyr * 26 were generated and transformed with EcoRI digested pP ⁇ CBHII according to the methods outlined in Examples 3 and 4.
  • DNA was extracted from strain P37P ⁇ CBH67, digested with EcoRI and Asp718. and subjected to agarose gel electrophoresis. The DNA from this gel was blotted to a membrane filter and hybridized with -p labelled pP ⁇ CBHII (FIG. 7) .
  • Lane A of FIG. 7 shows the hybridization pattern observed for DNA from an untransformed T. reesei strain. The 4.1 kb EcoRI fragment containing the wild-type cbh2 gene was observed.
  • Lane B shows the hybridization pattern observed for strain P37P ⁇ CBH67. The single 4.1 kb band has been eliminated and replaced by two bands of approximately 0.9 and 3.1 kb. This is the expected pattern if a single copy of the EcoRI fragment from pP ⁇ CBHII had integrated precisely at the cbh2 locus.
  • the T. reesei egll gene which encodes EGI, has been cloned as a 4.2 kb Hindlll fragment of genomic DNA from strain RL-P37 by hybridization with oligonucleotides synthesized according to the published sequence (Penttila et al., 1986, Gene 45:253-263; van Arsdell et al. , 1987, Bio/Technology 5:60-64).
  • a 3.6 kb Hindlll-BamHI fragment was taken from this clone and ligated with a 1.6 kb Hindlll- BamHI fragment containing the T.
  • reesei pyr4 gene obtained from pTpyr2 (see Example 2) and pUC218 (identical to pUC219, see Example 25, but with the multiple cloning site in the opposite orientation) cut with Hindlll to give the plasmid pEGIpyr4 (FIG. 8) .
  • Digestion of pEGlpyr4 with Hindlll would liberate a fragment of DNA containing only £. reesei genomic DNA (the egll and pyr4 genes) except for 24 bp of sequenced, synthetic DNA between the two genes and 6 bp of sequenced, synthetic DNA at one end (see FIG. 8) .
  • CYTOLASE 123 cellulase was fractionated in the following manner.
  • the normal distribution of cellulase components in this cellulase system is as follows: CBH I 45-55 weight percent
  • the fractionation was done using columns containing the following resins: Sephadex G-25 gel filtration resin from Sigma Chemical Company (St. Louis, Mo) , QA Trisacryl M anion exchange resin and SP Trisacryl M cation exchange resin from IBF
  • Biotechnics (Savage, Md) .
  • CYTOLASE 123 cellulase 0.5g
  • the desalted solution was then loaded onto a column of 20 ml of QA Trisacryl M anion exchange resin.
  • the fraction bound on this column contained CBH I and EG I. These components were separated by gradient elution using an aqueous gradient containing from 0 to about 500 mM sodium chloride.
  • the fraction not bound on this column contained CBH II and EG II.
  • cellulase systems which can be separated into their components include CELLUCAST (available from Novo Industry, Copenhagen, Denmark) , RAPIDASE (available from Gist Brocades, N.V. , Delft, Holland) , and cellulase systems derived from CELLUCAST (available from Novo Industry, Copenhagen, Denmark) , RAPIDASE (available from Gist Brocades, N.V. , Delft, Holland) , and cellulase systems derived from CELLUCAST (available from Novo Industry, Copenhagen, Denmark) , RAPIDASE (available from Gist Brocades, N.V. , Delft, Holland) , and cellulase systems derived from CELLUCAST (available from Novo Industry, Copenhagen, Denmark) , RAPIDASE (available from Gist Brocades, N.V. , Delft, Holland) , and cellulase systems derived from CELLUCAST (available from Novo Industry, Copenhagen, Denmark) , RAPIDASE (available from
  • A. Large Scale Extraction of EG III Cellulase Enzyme One hundred liters of cell free cellulase filtrate were heated to about 30°C.. The heated material was made about 4% wt/vol PEG 8000 (polyethylene glycol, MW of about 8000) and about 10% wt/vol anhydrous sodium sulfate. The mixture formed a two phase liquid mixture. The phases were separated using an SA-1 disk stack centrifuge. The phases were analyzed using silver staining isoelectric focusing gels. Separation was obtained for EG III and xylanase. The recovered composition contained about 20 to 50 weight percent of EG III.
  • EG III is conducted by fractionation from a complete fungal cellulase composition (CYTOLASE 123 cellulase, commercially available from Genencor International, South San Francisco, CA) which is produced by wild type Trichoderma reesei. Specifically, the fractionation is done using columns containing the following resins: Sephadex G-25 gel filtration resin from Sigma Chemical Company (St. Louis, Mo), QA Trisacryl M anion exchange resin and SF Trisacryl M cation exchange resin from IBF Biotechnics (Savage, Md) .
  • CYTOLASE 123 cellulase commercially available from Genencor International, South San Francisco, CA
  • the fractionation is done using columns containing the following resins: Sephadex G-25 gel filtration resin from Sigma Chemical Company (St. Louis, Mo), QA Trisacryl M anion exchange resin and SF Trisacryl M cation exchange resin from IBF Biotechnics (Savage, Md) .
  • CYTOLASE 123 cellulase 0.5g is desalted using a column of 3 liters of Sephadex G-25 gel filtration resin with 10 mM sodium phosphate buffer at pH 6.8. The desalted solution, is then loaded onto a column of 20 ml of QA Trisacryl M anion exchange resin. The fraction bound on this column contained CBH I and EG I. The fraction not bound on this column contains CBH II, EG II and EG III. These fractions are desalted using a column of Sephadex G-25 gel filtration resin equilibrated with 10 mM sodium citrate, pH 4.5. This solution, 200 ml, is then loaded onto a column of 20 ml of SP Trisacryl M cation exchange resin. The EG III was eluted with 100 L of an aqueous solution of 200 mM sodium chloride.
  • Trichoderma reesei genetically modified so as to be incapable of producing one or more of EG I, EG II, CBH I and/or CBH II.
  • the absence of one or more of such components will necessarily lead to more efficient isolation of EG III.
  • the EG III compositions described above may be further purified to provide for substantially pure EG III compositions, i.e., compositions containing EG III at greater than about 80 weight percent of protein.
  • substantially pure EG III protein can be obtained by utilizing material obtained from procedure A in procedure B or vica versa.
  • One particular method for further purifying EG III is by further fractionation of an EG III sample obtained in part b) of this Example 14. The further fraction was done on a FPLC system using a Mono-S-HR 5/5 column (available from Pharmacia LKB Biotechnology, Piscataway, NJ) .
  • the FPLC system consists of a liquid chromatography controller, 2 pumps, a dual path monitor, a fraction collector and a chart recorder (all of which are available from Pharmacia LKB Biotechnology, Piscataway, NJ) .
  • the fractionation was conducted by desalting 5 ml of the EG III sample prepared in part b) of this Example 14 with a 20 ml Sephadex G-25 column which had been previously equilibrated with 10 mM sodium citrate pH 4. The column was then eluted with 0-200 mM aqueous gradient of NaCl at a rate of 0.5 ml/minute with samples collected in 1 ml fractions.
  • EG III was recovered in fractions 10 and 11 and was determined to be greater than 90% pure by SDS gel electrophoresis. EG III of this purity is suitable for determining the N-terminal amino acid sequence by known techniques.
  • the first cellulase composition was a CBH I and II deleted cellulase composition prepared from Trichoderma reesei genetically modified in a manner similar to that described above so as to be unable to produce CBH I and CBH II components.
  • this cellulase composition does not contain CBH I and CBH II which generally comprise from about 58 to 70 percent of a cellulase composition derived from Trichoderma reesei.
  • this cellulase composition is necessarily substantially free of CBH I type and CBH II type cellulase components and accordingly, is enriched in EG components, i.e., EG I, EG II, EG III and the like.
  • the second cellulase composition was an approximately 20 to 40% pure fraction of EG III isolated from a cellulase composition derived from Trichoderma reesei via purification methods similar to part b) of Example 14.
  • This example examines the ability of different cellulase compositions to reduce the strength of cotton-containing fabrics.
  • This example employs an aqueous cellulase solution maintained at pH 5 because the activity of the most of the cellulase components derived from Trichoderma reesei is greatest at or near pH 5 and accordingly, strength loss results will be most evident when the assay is conducted at about this pH.
  • the first cellulase composition analyzed was a complete fungal cellulase system (CYTOLASE 123 cellulase, commercially available from Genencor International, South San Francisco, CA) produced by wild type Trichoderma reesei and is identified as GC010.
  • CYTOLASE 123 cellulase commercially available from Genencor International, South San Francisco, CA
  • the second cellulase composition analyzed was a
  • CBH II deleted cellulase composition prepared from Trichoderma reesei genetically modified in a manner similar to Examples 1 to 12 above and 22-30 below so as to be incapable of expressing CBH II and is identified as CBHIId.
  • CBH II comprises up to about 15 percent of the cellulase composition, deletion of this component results in enriched levels of CBH I, and all of the EG components.
  • the third cellulase composition analyzed was a CBH I and CBH II deleted cellulase composition prepared from Trichoderma reesei genetically modified in a manner similar to that described above so as to be incapable of expressing CBH I and CBH II and is identified as CBHI/lid.
  • CBH I and CBH II are not produced by this modified microorganism, the cellulase is necessarily free of all CBH I type components as well as all CBH components.
  • the last cellulase composition analyzed was a CBH I deleted cellulase composition prepared from Trichoderma reesei genetically modified in a manner similar to that described above so as to be incapable of expressing CBH I and is identified as CBHId. Insofar as the modified microorganism is incapable of expressing CBH I, this cellulase composition is necessarily free of all CBH I type cellulase components.
  • the cellulase compositions described above were tested for their effect on cotton-containing fabric strength loss in a launderometer.
  • the compositions were first normalized so that equal amounts of EG components were used.
  • Each cellulase composition was then added to separate solutions of 400 ml of a 20 mM citrate/phosphate buffer, titrated to pH 5, and which contains 0.5 ml of a non-ionic surfactant.
  • Each of the resulting solutions was then added to a separate launderometer canister.
  • Into these canisters were added a quantity of marbles to facilitate strength loss as well as a 16 inch x 20 inch cotton fabric (100% woven cotton, available as Style No. 467 from Test Fabrics, Inc., 200 Blackford Ave.
  • the canister was then closed and the canister lowered into the launderometer bath which was maintained at 43°C.
  • the canister was then rotated in the bath at a speed of at least about 40 revolutions per minute (rpms) for about 1 hour. Afterwards, the cloth is removed, rinsed well and dried in a standard drier.
  • FIG. 10 which shows that compositions containing CBH I, i.e., whole cellulase (GC010) and CBH II deleted cellulase, possessed the most strength loss whereas, the compositions containing no CBH I possessed significantly reduced strength loss as compared to whole cellulase and CBH II deleted cellulase. From these results, it is seen that the presence of CBH I type components in a cellulase composition imparts increased strength loss to the composition as compared to a similar composition not containing CBH I type components.
  • CBH I whole cellulase
  • strength loss resistant cellulase compositions are those compositions free of all CBH I type cellulase components and preferably, all CBH type cellulase components.
  • cellulase compositions will result in even lower strength loss at pH > 7 than those results observed at pH 5 shown in FIG 10.
  • the fabric can become stressed and when so stressed, it will contain broken and disordered fibers. Such fibers detrimentally impart a worn and dull appearance to the fabric.
  • the methods of this invention will result in fabric/color enhancement. This is believed to arise by removal of some of the broken and disordered fibers which has the effect of restoring the appearance of the fabric prior to becoming stressed.
  • Examples 17 and 18 illustrate this benefit of the present invention. It is noted that these examples employed worn cotton T-shirs (knits) as well as new cotton knits.
  • the faded appearance of the worn cotton-containing fabric arises from the accumulation on the fabric of loose and broken surface fibers over a period of time. These fibers give rise to a faded and matted appearance for the fabric and accordingly, the removal of these fibers is a necessary prerequisite to restoring the original sharp color to the fabric. Additionally, the accumulation of broken surface fibers on new cotton knits imparts a dull appearance to such fabrics. Accordingly, these experiments are necessarily applicable to color enhancement of stressed cotton-containing fabrics because both involve removal of surface fibers from the fabric.
  • the ability of EG components to enhance color in cotton-containing fabrics was analyzed in the following experiments. Specifically, the first experiment measures the ability of a complete cellulase system (CYTOLASE 123 cellulase, commercially available from Genencor International, South San Francisco, CA) produced by wild type Trichoderma reesei to remove surface fibers from a cotton-containing fabric over various pHs. This cellulase was tested for its ability to remove surface fibers in a launderometer.
  • CYTOLASE 123 cellulase commercially available from Genencor International, South San Francisco, CA
  • the canister was then closed and the canister lowered into the launderometer bath which was maintained at 43°C.
  • the canister was then rotated in the bath at a speed of at least about 40 revolutions per minute (rpms) for about 1 hour.
  • rpms revolutions per minute
  • the cloth is removed, rinsed well and dried in a standard drier.
  • the so treated fabrics were then analyzed for fiber removal by evaluation in a panel test. In particular, the fabrics (unmarked) were rated for levels of fiber by 6 individuals.
  • the fabrics were visually evaluated for surface fibers and rated on a 0 to 6 scale.
  • the scale has six standards to allow meaningful comparisons.
  • the standards are:
  • the fabric was a 100% cotton sheeting standardized test fabric (Style No. 439W) available from Test Fabrics, Inc., 200 Blackford Ave., Middlesex, NJ 08846 b All samples were treated with the same cellulase composition. Cellulase concentrations are in total protein. The launderometer treatment conditions are the same as set forth in Example 16 above. The fabric to be rated was provided a rating which most closely matched one of the standards. After complete analysis of the fabrics, the values assigned to each fabric by all of the individuals were added and an average value generated.
  • FIG. 11 illustrates that at the same pH, a dose dependent response is seen in the amount of fibers removed. That'is to say that at the same pH, the fabrics treated with more cellulase provided for higher levels of fiber removal as compared to fabrics treated with less cellulase. Moreover, the results of this figure demonstrate that at higher pHs, fiber removal can still be effected merely by using higher concentrations of cellulase.
  • the first cellulase composition analyzed was a complete cellulase system (CYTOLASE 123 cellulase, commercially available from Genencor International, South San Francisco, CA) produced by wild type Trichoderma reesei and is identified as GC010.
  • CYTOLASE 123 cellulase commercially available from Genencor International, South San Francisco, CA
  • the second cellulase composition analyzed was a cellulase composition substantially free of all CBH type components (including CBH I type components) which composition was prepared from Trichoderma reesei genetically modified in a manner similar to that described above so as to be incapable of expressing CBH I and CBH II and is identified as CBHI/II deleted.
  • CBH I and CBH II comprises up to about 70 percent of the cellulase composition, deletion of this component results in enriched levels of all of the EG components.
  • compositions were tested for their ability to remove surface fibers in a launderometer.
  • An appropriate amount of cellulase to provide for the requisite concentrations of EG components in the final compositions were added to separate solutions of 400 ml of a 20 mM citrate/phosphate buffer containing 0.5 ml of a non-ionic surfactant.
  • FIG. 12 is plotted on estimated EG concentrations.
  • FIG. 12 illustrates that both GC010 and CBH I/II Deleted cellulase compositions gave substantially identical fiber removal results at substantially equal endoglucanase concentrations.
  • the results of this figure suggest that it is the EG components which provide for fiber removal.
  • Example 17 This example is further to Example 17 and substantiates that CBH type components are not necessary for color enhancement and the purpose of this example is to examine the ability of cellulase compositions deficient in CBH type components to enhance color to cotton-containing fabrics.
  • the cellulase composition employed in this example was substantially free of all CBH type components (including CBH I type components) insofar as this composition was prepared from Trichoderma reesei genetically modified in a manner similar to that described above so as to be incapable of expressing CBH I and CBH II.
  • CBH I and CBH II comprises up to about 70 percent of the cellulase composition, deletion of this component results in enriched levels of all of the EG components.
  • the assay was conducted by adding a sufficient concentration of this cellulase composition to a 50 mM citrate/phosphate buffer to provide 500 ppm of cellulase.
  • the solution was titrated to pH 5 and contained 0.1 weight percent of nonionic surfactant (Grescoterg GL100 — commercially available from
  • cellulase compositions would be beneficial during fabric processing because such compositions would remove broken/loose fibers generated during processing without detrimental strength loss to the fabric.
  • This example demonstrates that the presence of CBH type components are not essential for imparting improved softness to cotton-containing fabrics.
  • this example employs a cellulase composition free of all CBH type components which composition is derived from Trichoderma reesei genetically engineered in the manner- described above so as to be incapable of producing CBH I and II components.
  • This cellulase composition was tested for its ability to soften terry wash cloth. Specifically, unsoftened 8.5 ounce cotton terry cloths, 14 inches by 15 inches (available as Style No. 420NS from Test Fabrics, Inc., 200 Blackford Ave., Middlesex, NJ 08846), were cut into 7 inch by 7.5 inch swatches.
  • the cellulase composition described above was tested for its ability to soften these swatches in a launderometer. Specifically, an appropriate amount of CBH I and II deleted cellulase to provide for 500 ppm, 250 ppm, 100 ppm, 50 ppm, and 10 ppm cellulase in the final cellulase solution was added to separate solutions of 400 ml of a 20 mM citrate/phosphate buffer containing 0.025 weight percent of a non-ionic surfactant (Triton X114) . Additionally, a blank was run containing the same solution but with no added cellulase. Samples so prepared were titrated to pH 5.
  • Triton X114 non-ionic surfactant
  • Each of the resulting solution was then added to a separate launderometer canister.
  • Into these canisters were added a quantity of marbles to facilitate softness as well as cotton swatches described above. All conditions were run in triplicate with two swatches per canister.
  • Each canister was then closed and the canister lowered into the launderometer bath which was maintained at 37°C. The canister was then rotated in the bath at a speed of at least about 40 revolutions per minute (rpms) for about 1 hour. Afterwards, the swatches were removed, rinsed well and dried in a standard drier.
  • the swatches were then analyzed for softness by evaluation in a preference test. Specifically, six panelists were given their own set of swatches and ask to rate them with respect to softness based on the softness criteria such as the pliability of the whole fabric. Swatches obtained from treatment with the five different enzyme concentrations and the blank were placed behind a screen and the panelists were asked to order them from least soft to most soft. Scores were assigned to each swatch based on its order relative to the other swatches; 5 being most soft and 0 being least soft. The scores from each panelists were cumulated and then averaged.
  • CBH type components are not essential for imparting improved feel and appearance to cotton-containing fabrics.
  • this example employs a cellulase composition derived from Trichoderma reesei genetically engineered in the manner described above so as to be incapable of producing any CBH type components (i.e., incapable of producing CBH I and II components) .
  • This cellulase composition was tested for its ability to improve the appearance of cotton- containing fabrics. Specifically, appropriately sized 100% cotton sheeting (available as Style No. 439W from Test Fabrics, Inc., 200 Blackford Ave., Middlesex, NJ 08846) were employed in the appearance aspects of this example.
  • the cellulase composition described above was tested for its ability to improve the appearance of these samples in a launderometer. Specifically, an appropriate amount of CBH I and II deleted cellulase to provide for 25 ppm, 50 ppm, and 100 ppm cellulase in the final cellulase solution was added to separate solutions of 400 ml of a 20 mM citrate/phosphate buffer containing 0.025 weight percent of a non-ionic surfactant (Triton X114) . Additionally, a blank was run containing the same solution but with no added cellulase. Samples so prepared were titrated to pH 5. Each of the resulting solutions was then added to a separate launderometer canister.
  • Triton X114 non-ionic surfactant
  • the CBH I and II deleted cellulase composition was then tested for its ability to improve the feel of cotton-containing fabrics. Specifically, appropriately sized 100% cotton sheeting (available as Style No. 439W from Test Fabrics, Inc., 200
  • the cellulase composition described above was tested for its ability to improve the feel of these samples in a launderometer. Specifically, an appropriate amount of cellulase to provide for 500 ppm, 1000 ppm, and 2000 ppm cellulase in the final cellulase solution was added to separate solutions of 24 L of a 20 IIH citrate/phosphate buffer. Additionally, a blank was run containing the same solution but with no added cellulase. All tests were conducted at pH.5.8 and run in an industial washer. The washer was operated at 50°C, a total volume of 24 L, a liquor to cloth ratio of 50:1 (weight to weight) and the washer was run for 30 minutes. Afterwards, the samples were removed and dried in an industrial dryer.
  • the panelists then assigned scores to each sample based on its order relative to the other samples; 4 having the best feel and 1 having the worst feel.
  • the scores from each panelists were cumulated and then averaged. The results of this test are as follows:
  • CBH type components are not essential for imparting a stone washed appearance to cotton-containing fabrics.
  • this example employs a cellulase composition derived from Trichoderma reesei genetically engineered in the manner described above so as to be incapable of producing any CBH type components (i.e., incapable of producing CBH I and II components) as well as a complete cellulase composition derived from Trichoderma reesei and which is available as Cytolase 123 cellulase from Genencor International, South San Francisco, California.
  • Samples were evaluated for their stonewashed appearance by 8 panelists. All eight panelists choose 100 ppm whole cellulase over non-enzyme treated pants as having the better stone washed look. Four of the 8 panelists choose the CBH I and II deleted cellulase treated pants over whole cellulase as having the better stone washed look; whereas the other four panelists choose the whole cellulase treated pants as having the better stone washed look. These results indicate that the CBH I and II deleted cellulase treated pants were indistinguishable from whole cellulase treated pants and that CBH I and/or CBH II are not not essential for imparting a stone washed appearance to cotton- containing fabrics.
  • cellulase compositions free of CBH I type components and derived from microorganisms other than Trichoderma reesei could be used in place of the cellulase compositions described in these examples.
  • the source of the cellulase composition containing the EG type components is not important to this invention and any fungal cellulase composition containing one or more EG type components and substantially free of all CBH I type components can be used herein.
  • fungal cellulases for use in preparing the fungal cellulase compositions used in this invention can be obtained from Trichoderma koningii. Pencillum sp.
  • cellulases can be used, i.e., CELLUCAST (available from Novo Industry, Copenhagen, Denmark) , RAPIDASE (available from Gist Brocades, N.V., Delft, Holland), and the like.
  • CELLUCAST available from Novo Industry, Copenhagen, Denmark
  • RAPIDASE available from Gist Brocades, N.V., Delft, Holland
  • RutC30 (Sheir-Neiss and Montenecourt, (1984), Appl. Microbiol. Biotechnol. 20:46-53) was obtained by the method outlined in Example 1. Protoplasts of this strain were transformed with undigested pEGIpyr4 and stable transformants were purified.
  • the resulting mycelium was washed with sterile water and added to 50 ml of TSF medium (Q * 05M citrate-phosphate buffer, pH.5.0; Avicel microcrystalline cellulose, 10 g/1; KH 2 P0 4 , 2.0 g/1; (NH 4 ) 2 S0 4 , 1.4 g/1; proteose peptone, 1.0 g/1; Urea, 0.3 g/1; MgS0 4 .7H 2 0, 0.3 g/1; CaCl 2 , 0.3 g/1;
  • FeS0 4 .7H 2 5.0 mg/1; MnS0 4 .H 2 0, 1.6 mg/1; ZnS0 4 , 1.4 mg/1; CoCl 2 , 2.0 mg/1; 0.1% Tween 80). These cultures were incubated with shaking for a further four days at 28°C. Samples of the supernatant were taken from these cultures and assays designed to measure the total amount of protein and of endoglucanase activity were performed as described below.
  • the endoglucanase assay relied on the release of soluble, dyed oligosaccharides from Remazol Brilliant Blue-carboxymethylcellulose (RBB-CMC, obtained from MegaZyme, North Rocks, NSW, Australia) .
  • the substrate was prepared by adding 2 g of dry RBB-CMC to 80 ml of just boiled deionized water with vigorous stirring. When cooled to room temperature, 5 ml of 2 M sodium acetate buffer (pH 4.8) was added and the pH adjusted to 4.5. The volume was finally adjusted to 100 ml with deionized water and sodium azide added to a final concentration of 0.02%. Aliquots of T.
  • pEGIpyr4 transformant culture supernatant or 0.1 M sodium acetate as a blank (10- 20 ⁇ l) were placed in tubes, 250 ⁇ l of substrate was added and the tubes were incubated for 30 minutes at 37°C. The tubes were placed on ice for 10 minutes and l ml of cold precipitant (3.3% sodium acetate, 0.4% zinc acetate, pH 5 with HC1, 76% ethanol) was then added. The tubes were vortexed and allowed to sit for five minutes before centrifuging for three minutes at approximately 13,000 x g-. The optical density was measured spectrophotometrically at a wavelength of 590-600 nm.
  • the protein assay used was the BCA
  • BCA bovine serum albumin
  • the transformants described in this Example were obtained using intact pEGIpyr4 and will contain DNA sequences integrated in the genome which were derived from the pUC plasmid. Prior to transformation it would be possible .to digest pEGlpyr4 with Hindlll and isolate the larger DNA fragment containing only _£. reesei DNA. Transformation of T. reesei with this isolated fragment of DNA would allow isolation of transformants which overproduced EGI and contained no heterologous DNA sequences except for the two short pieces of synthetic DNA shown in FIG. 8. It would also be possible to use PEGIPV ⁇ 4 to transform a strain which was deleted for either the cbhl gene, or the cbh2 gene, or for both genes. In this way a strain could be constructed which would over-produce EGI and produce either a limited range of, or no, exo-cellobiohydrolases.
  • Example 22 could be used to produce T. reesei strains which would over-produce any of the other cellulase components, xylanase components or other proteins normally produced by T. reesei.
  • a plasmid, pCEPCl was constructed in which the coding sequence for EGI was functionally fused to the promoter from the cbhl gene. This was achieved using in vitro, site-specific mutagenesis to alter the DNA sequence of the cbhl and egll genes in order to create convenient restriction endonuclease cleavage sites just 5' (upstream) of their respective translation initiation sites. DNA sequence analysis was performed to verify the expected sequence at the junction between the two DNA segments. The specific alterations made are shown in FIG. 14.
  • the DNA fragments which were combined to form pCEPCl were inserted between the EcoRI sites of pUC4K and were as follows (see FIG. 15) : A) A 2.1 kb fragment from the 5' flanking region of the cbhl locus. This includes the promoter region and extends to the engineered Bell site and so contains no cbhl coding sequence. B) A 1.9 kb fragment of genomic DNA from the egll locus starting at the 5' end with the engineered BamHI site and extending through the coding region and including approximately 0.5 kb beyond the translation stop codon. At the 3' end of the fragment is 18 bp derived from the pUC218 multiple cloning site and a 15 bp synthetic oligonucleotide used to link this fragment with the fragment below.
  • the plasmid, pCEPCl was designed so that the EGI coding sequence would be integrated at the cbhl locus, replacing the coding sequence for CBHI without introducing any foreign DNA into the host strain. Digestion of this plasmid with EcoRI liberates a fragment which includes the cbhl promoter region, the egll coding sequence and transcription termination region, the ⁇ reesei p ⁇ r4 gene and a segment of DNA from the 3' (downstream) flanking region of the cbhl locus (see Fig. 15) .
  • a pyr4 defective strain of T ⁇ _ reesei RutC30 (Sheir-Neiss, supra) was obtained by the method outlined in Example 1. This strain was transformed with pCEPCl which had been digested with EcoRI. Stable transformants were selected and subsequently cultured in shaker flasks for cellulase production as described in Example 22. In order to visualize the cellulase proteins, isoelectric focusing gel electrophoresis was performed on samples from these cultures using the method described in Example 7. Of a total of 23 transformants analysed in this manner 12 were found to produce no CBHI protein, which is the expected result of integration of the CEPCl DNA at the cbhl locus.
  • Southern blot analysis was used to confirm that integration had indeed occurred at the cbhl locus in some of these transformants and that no sequences derived from the bacterial plasmid vector (pUC4K) were present (see Fig. 16) .
  • the DNA from the transformants was digested with Pstl before being subjected to electrophoresis and blotting to a membrane filter.
  • the resulting Southern blot was probed with radiolabelled plasmid pUC4K::cbhl (see Example 2) .
  • the probe hybridised to the cbhl gene on a 6.5 kb fragment of DNA from the untransformed control culture (FIG. 16, lane A) .
  • Endoglucanase activity assays were performed on samples of culture supernatant from' the untransformed culture and the transformants exactly as described in Example 22 except that the samples were diluted 50 fold prior to the assay so that the protein concentration in the samples was between approximately 0.03 and 0.07 mg/ml.
  • the results of assays performed with the untransformed control culture and four different transformants are shown in Table 2.
  • Transformants CEPC1-103 and CEPC1-112 are examples in which integration of the CEPCl fragment had led to loss of CBHI production.
  • the eg!3 gene encoding EGII (previously referred to as EGIII by others) , has been cloned from T. reesei and the DNA sequence published (Saloheimo et al., 1988, Gene 63:11-21).
  • the latter vector, pUC219 is derived from pUC119 (described in Wilson et al., 1989, Gene 77:69-78) by expanding the multiple cloning site to include restriction sites for Bglll, Clal and Xhol.
  • the T ⁇ . reesei pyr4 gene present on a 2.7 kb Sail fragment of genomic DNA, was inserted into a Sail site within the EGII coding sequence to create plasmid pEGII::P-l (FIG. 17) .
  • the plasmid, pEGII::P-l can be digested with Hindlll and BamHI to yield a linear fragment of DNA derived exclusively from ______ reesei except for 5 bp on one end and 16 bp on the other end, both of which are derived from the multiple cloning site of pUC219.
  • Ti reesei strain GC69 will be transformed with pEGII: :P-l which had been previously digested with Hindlll and BamHI and stable transformants will be selected.
  • Total DNA will be isolated from the transformants and Southern blot analysis used to identify those transformants in which the fragment of DNA containing the pyr4 and eg!3 genes had integrated at the egl3 locus and consequently disrupted the EGII coding sequence. The transformants will be unable to produce EGII.
  • P37P ⁇ CBH67 (from Example 11) was obtained by the method outlined in Example 1. This strain P37P ⁇ 67P" 1 was transformed with pEGII::P-l which had been previously digested with Hindlll and BamHI and stable transformants were selected. Total DNA was isolated from transformants and Southern blot analysis used to identify strains in which the fragment of DNA containing the pyr4 and egl3 genes had integrated at the eg!3 locus and consequently disrupted the EGII coding sequence. The Southern blot illustrated in FIG.
  • the plasmid pP ⁇ EGI-1 can be digested with
  • Example 28 The expectation that the EGI gene could be inactivated using the method outlined in Example 28 is strengthened by this experiment.
  • a plasmid, p ⁇ EGIpyr-3 was constructed which was similar to pP ⁇ EGI-1 except that the Aspergillus niger p ⁇ r4 gene replaced the T ⁇ reesei pyr4 gene as selectable marker.
  • the egll gene was again present as a 4.2 kb Hindlll fragment inserted at the Hindlll site of pUClOO.
  • the same internal l kb EcoRV fragment was removed as during the construction of pP ⁇ EGI-1 (see Example 28) but in this case it was replaced by a 2.2 kb fragment containing the cloned A ⁇ .
  • a pyr4 deficient derivative of strain A22 (from Example 27) will be obtained by the method outlined in Example 1.
  • This strain will be transformed with pP ⁇ EGI-1 which had been previously digested with Hindlll to release a DNA fragment comprising only T. reesei genomic DNA having a segment of the egll gene at either end with part of the EGI coding sequence replaced by the p ⁇ r4 gene.
  • Stable pyr4+ transformants will be selected and total DNA isolated from the transformants.
  • the DNA will be probed with 32 P labelled pP ⁇ EGI-1 after Southern blot analysis in order to identify transformants in which the fragment of DNA containing the pyr4 gene and egll sequences has integrated at the egll locus and consequently disrupted the EGI coding sequence.
  • the transformants identified will be unable to produce CBHI, CBHII, EGI and EGII.

Abstract

Procédés améliorés de traitement de tissus contenant du coton et tissus produits selon ces procédés. Les procédés consistent notamment à mettre en contact des tissus contenant du coton avec une solution aqueuse contenant une composition de cellulase fongique renfermant un ou plusieurs constituants de type EG et un ou plusieurs constituants de type CBH I, ladite composition de cellulase ayant un rapport pondéral de protéine de tous les constituants de type EG et de tous les constituants de type CBH I supérieur à 5:1. Les tissus contenant du coton ainsi traités présentent une perte de résistance moindre comparée à des tissus traités à l'aide d'une composition de cellulase contenant des quantités supérieures de constituants de type CBH I.
PCT/US1991/007275 1990-10-05 1991-10-04 Procedes de traitement a la cellulase de tissus contenant du coton WO1992006183A1 (fr)

Priority Applications (5)

Application Number Priority Date Filing Date Title
JP3517030A JPH06502223A (ja) 1990-10-05 1991-10-04 セルラーゼによる綿含有織物の処理方法
EP91918328A EP0551386B1 (fr) 1990-10-05 1991-10-04 Procedes de traitement a la cellulase de tissus contenant du coton
DE69133352T DE69133352T2 (de) 1990-10-05 1991-10-04 Methoden zur behandlung baumwolle-enthaltender fasern mit zellulase
AT91918328T ATE257511T1 (de) 1990-10-05 1991-10-04 Methoden zur behandlung baumwolle-enthaltender fasern mit zellulase
FI931492A FI931492A0 (fi) 1990-10-05 1993-04-01 Foerfaranden foer behandling av bomullsinnehaollande tyger med cellulas

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US59391990A 1990-10-05 1990-10-05
US67886590A 1990-10-05 1990-10-05
US593,919 1990-10-05

Publications (1)

Publication Number Publication Date
WO1992006183A1 true WO1992006183A1 (fr) 1992-04-16

Family

ID=27081830

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1991/007275 WO1992006183A1 (fr) 1990-10-05 1991-10-04 Procedes de traitement a la cellulase de tissus contenant du coton

Country Status (1)

Country Link
WO (1) WO1992006183A1 (fr)

Cited By (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993017175A1 (fr) * 1992-02-28 1993-09-02 Genencor International, Inc. Procedes d'amelioration de la qualite d'impression de compositions de colorants sur des tissus en coton
WO1993017174A1 (fr) * 1992-02-28 1993-09-02 Genencor International, Inc. Procedes d'amelioration de la qualite d'impression de compositions pigmentaires sur des tissus en cotons
WO1993022428A1 (fr) * 1992-05-01 1993-11-11 Genencor International, Inc. Procedes de traitement de tissus a base de coton avec de la cellulase enrichie en cbh i
WO1993025655A1 (fr) * 1992-06-12 1993-12-23 Genencor International, Inc. Compositions enzymatiques et procedes de production d'un aspect lave par abrasion sur du tissu denim teinte par indigo
EP0577722A1 (fr) * 1991-03-29 1994-01-12 Genencor International, Inc. Procede de traitement par la cellulase des tissus contenant du coton
WO1994023113A1 (fr) * 1993-03-30 1994-10-13 Genencor International, Inc. Procedes de reduction de la formation de coton egraine lors du traitement de tissus cellulosiques contenant du coton et ne contenant pas de coton
WO1994026880A1 (fr) * 1993-05-10 1994-11-24 Gist-Brocades N.V. Action combinee des endoglucanases et des cellobiohydrolases
WO1994029426A1 (fr) * 1993-06-11 1994-12-22 Genencor International, Inc. Compositions enzymatiques et procedes de production de croise de coton teint en indigo presentant l'aspect d'un tissu lave a la pierre
WO1995025841A1 (fr) * 1994-03-18 1995-09-28 Genencor International, Inc. Procedes pour traiter avec de la cellulase des tissus ne contenant pas de coton
US5707858A (en) * 1992-11-30 1998-01-13 Novo Nordisk A/S Process for the treatment of cellulosic fabrics with cellulases
US5770104A (en) * 1990-10-05 1998-06-23 Genencor International, Inc. Detergent compositions containing substantially pure EG III cellulase
US6162782A (en) * 1990-10-05 2000-12-19 Genencor International, Inc. Detergent compositions containing cellulase compositions deficient in CBH I type components
US6251144B1 (en) 1992-06-12 2001-06-26 Genencor International, Inc. Enzymatic compositions and methods for producing stonewashed look on indigo-dyed denim fabric and garments
US6294366B1 (en) 1997-09-19 2001-09-25 Clariant Finance (Bvi) Limited Compositions and methods for treating cellulose containing fabrics using truncated cellulase enzyme compositions
ES2217918A1 (es) * 2001-06-21 2004-11-01 Cognis Iberia S.L. Productos acabados para el tratamiento de textiles.
WO2018067599A1 (fr) 2016-10-04 2018-04-12 Danisco Us Inc. Production de protéines dans des cellules fongiques filamenteuses en l'absence de substrats inducteurs
WO2020028126A1 (fr) 2018-07-30 2020-02-06 Danisco Us Inc Souches fongiques filamenteuses mutantes et génétiquement modifiées comprenant des phénotypes de productivité protéique améliorés et procédés associés
WO2021216302A1 (fr) 2020-04-22 2021-10-28 Danisco Us Inc Compositions et méthodes pour une production améliorée de protéines dans des cellules fongiques filamenteuses
WO2022106072A1 (fr) 2020-11-18 2022-05-27 Aplicacion Y Suministros Textiles, S.A.U. Procédé de délavage à la pierre de textiles

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4894338A (en) * 1984-04-13 1990-01-16 Oy Alko Ab Yeast strains producing cellulolytic enzymes and methods and means for constructing them

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4894338A (en) * 1984-04-13 1990-01-16 Oy Alko Ab Yeast strains producing cellulolytic enzymes and methods and means for constructing them

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
See also references of EP0551386A4 *
The Biochemical Journal, Volume 260, Number 1, issued 15 May 1989, WOOD et al., "Synergism between enzyme components of Penicillium Pinophilum cellulase in solubilizing hydrogen bondordered cellulose", pages 37-43, see entire document. *

Cited By (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6162782A (en) * 1990-10-05 2000-12-19 Genencor International, Inc. Detergent compositions containing cellulase compositions deficient in CBH I type components
US5770104A (en) * 1990-10-05 1998-06-23 Genencor International, Inc. Detergent compositions containing substantially pure EG III cellulase
EP0577722A4 (fr) * 1991-03-29 1995-01-18 Genencor Int Procede de traitement par la cellulase des tissus contenant du coton.
EP0577722A1 (fr) * 1991-03-29 1994-01-12 Genencor International, Inc. Procede de traitement par la cellulase des tissus contenant du coton
WO1993017174A1 (fr) * 1992-02-28 1993-09-02 Genencor International, Inc. Procedes d'amelioration de la qualite d'impression de compositions pigmentaires sur des tissus en cotons
WO1993017175A1 (fr) * 1992-02-28 1993-09-02 Genencor International, Inc. Procedes d'amelioration de la qualite d'impression de compositions de colorants sur des tissus en coton
US5352243A (en) * 1992-02-28 1994-10-04 Genencor International, Inc. Methods of enhancing printing quality of pigment compositions onto cotton fabrics
WO1993022428A1 (fr) * 1992-05-01 1993-11-11 Genencor International, Inc. Procedes de traitement de tissus a base de coton avec de la cellulase enrichie en cbh i
US5668009A (en) * 1992-05-01 1997-09-16 Genencor International, Inc. Methods for treating cotton-containing fabrics with CBH I enriched cellulase
US6251144B1 (en) 1992-06-12 2001-06-26 Genencor International, Inc. Enzymatic compositions and methods for producing stonewashed look on indigo-dyed denim fabric and garments
WO1993025655A1 (fr) * 1992-06-12 1993-12-23 Genencor International, Inc. Compositions enzymatiques et procedes de production d'un aspect lave par abrasion sur du tissu denim teinte par indigo
US5707858A (en) * 1992-11-30 1998-01-13 Novo Nordisk A/S Process for the treatment of cellulosic fabrics with cellulases
WO1994023113A1 (fr) * 1993-03-30 1994-10-13 Genencor International, Inc. Procedes de reduction de la formation de coton egraine lors du traitement de tissus cellulosiques contenant du coton et ne contenant pas de coton
WO1994026880A1 (fr) * 1993-05-10 1994-11-24 Gist-Brocades N.V. Action combinee des endoglucanases et des cellobiohydrolases
WO1994029426A1 (fr) * 1993-06-11 1994-12-22 Genencor International, Inc. Compositions enzymatiques et procedes de production de croise de coton teint en indigo presentant l'aspect d'un tissu lave a la pierre
WO1995025841A1 (fr) * 1994-03-18 1995-09-28 Genencor International, Inc. Procedes pour traiter avec de la cellulase des tissus ne contenant pas de coton
US6294366B1 (en) 1997-09-19 2001-09-25 Clariant Finance (Bvi) Limited Compositions and methods for treating cellulose containing fabrics using truncated cellulase enzyme compositions
ES2217918A1 (es) * 2001-06-21 2004-11-01 Cognis Iberia S.L. Productos acabados para el tratamiento de textiles.
WO2018067599A1 (fr) 2016-10-04 2018-04-12 Danisco Us Inc. Production de protéines dans des cellules fongiques filamenteuses en l'absence de substrats inducteurs
WO2020028126A1 (fr) 2018-07-30 2020-02-06 Danisco Us Inc Souches fongiques filamenteuses mutantes et génétiquement modifiées comprenant des phénotypes de productivité protéique améliorés et procédés associés
WO2021216302A1 (fr) 2020-04-22 2021-10-28 Danisco Us Inc Compositions et méthodes pour une production améliorée de protéines dans des cellules fongiques filamenteuses
WO2022106072A1 (fr) 2020-11-18 2022-05-27 Aplicacion Y Suministros Textiles, S.A.U. Procédé de délavage à la pierre de textiles

Similar Documents

Publication Publication Date Title
EP0551386B1 (fr) Procedes de traitement a la cellulase de tissus contenant du coton
US5246853A (en) Method for treating cotton-containing fabric with a cellulase composition containing endoglucanase components and which composition is free of exo-cellobiohydrolase I
WO1992006221A1 (fr) Procedes de traitement a la cellulase de tissus contenant du coton
US5650322A (en) Methods for stonewashing fabrics using endoglucanases
WO1992006183A1 (fr) Procedes de traitement a la cellulase de tissus contenant du coton
WO1992006210A1 (fr) Compositions de detergent contenant des compositions de cellulase enrichies en constituants du type endoglucanase acide
WO1992017574A1 (fr) Procede de traitement par la cellulase des tissus contenant du coton
US5668009A (en) Methods for treating cotton-containing fabrics with CBH I enriched cellulase
US5525507A (en) Methods for treating cotton-containing fabric with cellulase composition containing endoglucanase component and which is free of all CBH I component
EP0692041A1 (fr) Procedes de reduction de la formation de coton egraine lors du traitement de tissus cellulosiques contenant du coton et ne contenant pas de coton
WO1992017572A1 (fr) Procedes de traitement par la cellulase des tissus contenant du coton
US5654193A (en) Methods for treating cotton containing fabrics with cellulase
EP0699249B1 (fr) Procedes pour traiter avec de la cellulase des tissus ne contenant pas de coton

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): CA FI JP US

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IT LU NL SE

WWE Wipo information: entry into national phase

Ref document number: 931492

Country of ref document: FI

WWE Wipo information: entry into national phase

Ref document number: 2093428

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 1991918328

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1991918328

Country of ref document: EP

WWG Wipo information: grant in national office

Ref document number: 1991918328

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 1991918328

Country of ref document: EP